Cardiovascular disease, fibrinogen and the acute phase response associations with lipids and blood pressure in patients with chronic renal disease

Atherosclerosis

Volumn 137, Issue 1, 1998, Pages 133-139

  Irish, Ashley ^a  

^a CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Cardiovascular disease; Fibrinogen; Hypertension; Interleukin 6; Renal disease; Total:HDL cholesterol ratio

Indexed keywords

FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6;

ACUTE PHASE RESPONSE; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMODIALYSIS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ACUTE-PHASE REACTION; ADULT; AGE FACTORS; AGED; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, VLDL; CROSS-SECTIONAL STUDIES; DATA INTERPRETATION, STATISTICAL; DIASTOLE; FEMALE; FIBRINOGEN; HUMANS; HYPERTENSION; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; LEUKOCYTE COUNT; LIPIDS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PLATELET COUNT; PROSPECTIVE STUDIES; PROTEINURIA; RENAL DIALYSIS; SERUM ALBUMIN; SEX FACTORS; SMOKING; SYSTOLE;

EID: 0032478147     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00273-6     Document Type: Article

References (33)

1. Brown JH, Short CD, Mallick NP. Ischaemic heart disease, lipids and the kidney. In: Bourke E, Mallick NP, Pollak VE, editors. Moving Points in Nephrology. Basel: Karger, 1993:198-219.
2. Green D., Stone N.J., Krumlovsky F.A. Putative atherogenic factors in patients with chronic renal failure. Prog Cardiovasc Dis. 26(2):1983;133-143.
3. Kannel W.B., Wolf P.A., Castelli W.P., D'Agostino R.B. Fibrinogen and risk of cardiovascular disease. J Am Med Assoc. 258(9):1987;1183-1186.
4. Koenig W., Ernst E. Fibrinogen and atherothrombogenesis. Curr Opin Lipidol. 4(6):1993;471-476.
5. Meade T.W., Mellows S., Brozovic M.et al. Haemostatic function and ischaemic heart disease: Principal results of The Northwick Park Heart Study. Lancet. ii:1986;533-537.
6. Thompson S.G., Kienast J., Pyke S.D.M., Haverkrate F., Van de Loo J.C.W. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med. 332(10):1995;635-641.
7. Koster T., Rosendaal F.R., Reitsma P.H., van der Velden P.A., Briet E., Vandenbroucke J.P. Factor VII and fibrinogen levels as risk factors for venous thrombosis. Thromb Haemost. 71(6):1994;719-722.
8. Heinrich J., Balleisen L., Schulte H.G.A., van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk: results from the PROCAM study in healthy men. Arterioscler Thromb. 14:1994;54-59.
9. Smith E.B., Thompson W.D. Fibrin as a factor in atherogenesis. Thromb Res. 73:1994;1-19.
10. Vaziri N.D., Gonzales E., Barton C.H., Chen H.T., Nguyen Q., Arquilla M. Factor XIII and its substrates, fibronectin, fibrinogen, and alpha-2-antiplasmin, in plasma and urine of patients with nephrosis. J Lab Clin Med. 117:1991;152-156.
11. Nakamura Y., Chida Y., Tomura S. Enhanced coagulation-fibrinolysis in patients on regular haemodialysis. Nephron. 58:1991;201-204.
12. Cavagna R., Sciavon R., Tessarin C.et al. Risk factors of ischaemic cardiac disease in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int. 13(Suppl 2):1993;S402-S405.
13. Tomura S., Nakamura Y., Deguchi F., Ando R., Chida Y., Marumo F. Coagulation and fibrinolysis in patients with chronic renal failure undergoing conservative treatment. Thromb Res. 64:1991;81-90.
14. Attman P.A., Alaupovic P. Lipid abnormalities in chronic renal insufficiency. Kidney Int. 39(Suppl 31):1991;S16-S23.
15. Chan M.K., Varghese Z., Moorhead J.F. Lipid abnormalities in uremia, dialysis and transplantation. Kidney Int. 19:1981;625-637.
16. Arnadottir M., Thysell H., Dallongeville J., Fruchart J.-C., Nilsson-Ehle P. Evidence that reduced lipoprotein lipase activity is not a primary pathogenetic factor for hypertriglyceridaemia in renal failure. Kidney Int. 48:1995;779-784.
17. Takeda Y., Chen A.Y. Fibrinogen metabolism and distribution in patients with the nephrotic syndrome. J Lab Clin Med. 70:1967;678.
18. Le J., Vilcek J. Interleukin 6: A multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab Invest. 61(6):1989;588-602.
19. Gauldie J., Northeman W., Fey G.H. IL-6 functions as an exocrine hormone in inflammation. J Immunol. 144(10):1990;3804-3808.
20. Friedlander M.A., Hilbert C.M., Wu Y.C., Rich E.A. Role of dialysis modality in responses of blood monocytes and peritoneal macrophages to endotoxin stimulation. Kidney Int. 22(1):1993;11-23.
21. Girndt M., Kohler H., Schiedhelm-Weick E., Schlaak J.E., Meyer zum Buschenfelde K.H., Fleischer B. Production of interleukin-6, tumour necrosis factor α. and interleukin-10 in vitro correlates with the clinical immune defect in chronic haemodialysis patients. Kidney Int. 47:1995;559-565.
22. Herbelin A., Ureña P., Nguyen A.T., Zingraff J., Descamps-Latscha B. Elevated circulating levels of interleukin-6 in patients with chronic renal failure. Kidney Int. 39:1991;954-960.
23. Herbelin A., Nguyen A.T., Zingraff J., Urena P., Descamps-Latscha B. Influence of uremia and hemodialysis on circulating interleukin-1 and tumour necorosis factor α Kidney Int. 37:1990;116-125.
24. Pereira B.J.G., Shapiro L., King A.J., Falagas M.E., Strom J.A., Dinarello C.A. Plasma levels of IL-1β, TNFα and their specific inhibitors in undialyzed chronic renal failure. CAPD and hemodialysis patients. Kidney Int. 45:1994;890-896.
25. Tencer J., Thysell H., Westman K., Rippe B. Elevated plasma levels of acute phase proteins in mesangioproliferative glomerulonephritis, membranous nephropathy and IgA nephropathy. Scand J Urol Nephrol. 29:1995;5-9.
26. Liuzzo G., Biasucci L.M., Gallimore R.et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med. 331(7):1994;417-424.
27. Alexander R.W. Inflammation and coronary heart disease. N Engl J Med. 331(7):1994;468-469.
28. Durrington P.N. How HDL protects against atheroma. Lancet. 342:1993;1315-1316.
29. Pepys MB. The acute phase response and C-reactive protein. In: Weatherall DJ, Ledingham JGG, Warrell DA, editors. The Oxford Textbook of Medicine. 2nd ed. Oxford: Oxford University Press, 1987:9.157-9.164.
30. Steel D.M., Whitehead A.S. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today. 15(2):1994;81-88.
31. Letcher R.L., Chien S., Pickering T.G., Sealey J.E., Laragh J.H. Direct relationship between blood pressure and blood viscosity in normal and hypertensive subjects. Role of fibrinogen and concentration. Am J Med. 70:1981;1195-1202.
32. Pedrinelli R., Giampietro O., Carmassi F.et al. Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet. 344:1994;14-18.
33. Irish A.B., Green F.R. Environmental and genetic determinants of the hypercoagulable state and cardiovascular disease in renal transplant recipients. Nephrol Dial Transplant. 12:1997;167-173.